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Background: Swiprosin-1 was identified in human CD8＋ 
lymphocytes, mature B cells and non-lymphonoid tissue. We 
have recently reported that swiprosin-1 is expressed in mast 
cells and up-regulated in both in vitro and in vivo. Methods: 
The expression of cytokines and swiprosin-1 were deter-
mined by by real time PCR and conventional PCR. Pharma-
cological inhibitors were treated to investigate potential 
mechanism of swiprosin-1 in mast cell activation. Actin con-
tent was evaluated by confocal microscopy and flow cy-
tometry. Results: The swiprosin-1 augmented PMA/A23187- 
induced expression of cytokines and release of histamine. 
However, knock-down of swiprosin-1 showed only a modest 
effect on PMA/A23187-induced cytokine expression, sug-
gesting that swiprosin-1 has gain-of-function characteristics. 
Swiprosin-1 was found in microvilli-like membrane protru-
sions and highly co-localized with F-actin. Importantly, either 
disruption of actin by cytochalasin B or inhibition of PI3 kin-
ase, an enzyme involved in actin remodeling, by wortmannin 
blocked cytokine expression only in swiprosin-1-overex-
pressing cells. Conclusion: These results suggest that swi-
prosin-1 modulates mast cell activation potentially through 
actin regulation.
[Immune Network 2009;9(6):274-284]
INTRODUCTION
Swiprosin-1 was first identified in human lymphocytes, pre-
dominantly in CD8
＋ lymphocytes (1) and later in immature 
B cells, resting and activated B cells, and non-lymphoid tis-
sue, especially in the brain (2). We have recently found that 
swiprosin-1 is also expressed in mast cells and up-regulated 
in  both  in  vitro  cultured  mast  cells  by  phorbol  ester  or 
cross-linking of FcεR1 and in vivo model tissues of passive 
cutaneous anaphylaxis and atopic dermatitis (3). Targeted in-
hibition  of  the  specific  protein  kinase  C  (PKC)  isotypes  by 
siRNA  revealed  that  PKC-βI/η are  involved  in  the  ex-
pression of swiprosin-1 in the human mast cell line HMC-1. 
In contrast, down-regulation of swiprosin-1 by A23187 or ion-
omycin suggests that calcium-signaling plays a negative role 
(3).
    However, the functions of swiprosin-1 in mast cells are still 
largely  unknown.  In  the  previous  paper,  we  only  reported 
that  the  ectopic  expression  of  swiprosin-1  augments  PMA/ 
A23187-induced  NF-κB  promoter  activity  and  cytokine  ex-
pression  including  IL-3  and  IL-8  (3).  However,  the  mecha-
nism how swiprosin-1 involves in the cytokine production in 
m a s t  c e l l s  i s  n o t  i n v e s t i g a t e d .  I n  o t h e r  c e l l  t y p e s ,  t h e  o n l y  
reported functions are that swiprosin-1 is associated with lipid 
rafts in the immature B-cell line WEHI231 and that it partic-
ipates  in  enhancement  of  BCR  signals  and  contributes  to 
BCR-induced  apoptosis  (2,4).
    Mast  cells  are  broadly  distributed  throughout  mammalian 
tissues and play a critical role in a variety of biological re-
sponses (5-7). Typically, mast cells are considered in associa-
tion with immediate-type hypersensitivity (5). However, sev-
eral recent reports have provided evidence for the possible 
participation  of  mast  cells  in  more  persistent,  and  even  in 
chronic,  inflammatory  and  immunological,  responses  (8,9). 
Of note, a variety of cytokines including IL-3, IL-4, IL-5, IL-6, Swiprosin-1 Regulates HMC-1 Cytokine Expression
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IL-8, TNF-α, and IFN-γ (10-12) are produced in mast cells 
and play an important role in immunological processes other 
than  IgE-mediated  hypersensitivity  reactions.  Given  the  po-
tential  importance  of  mast cell-derived  cytokines in  physio-
logical or pathological immune reactions, it is essential to un-
derstand  the  signaling  pathways  and  molecules  involved  in 
cytokine regulation in mast cells. Until recently, however, on-
ly a limited number of reports have examined the regulatory 
mechanism  of  cytokine  expression  in  mast  cells,  while  the 
mechanism of mast cell degranulation, mediated by the high 
affinity IgE receptor (FcεR1), is relatively well characterized 
(7).
    As part of genome-wide approaches to finding novel genes 
that may be involved in mast cell activation, we have pre-
viously found that swiprosin-1 is over-induced in the human 
mast cell line HMC-1 stimulated with PMA/A23187 (3). In the 
present study, we examined, using confocal microscopy, the 
three-dimensional  localization  of  s w i p r o s i n - 1  i n  v a r i o u s  c e l l  
lines, including HMC-1 cells, 293T cells, and COS-7 cells. We 
then  asked  whether  swiprosin-1  potentially  modulates  mast 
cell  activation  and  cytokine  expression  in  relation  to  its 
localization.
    Database mining revealed that swiprosin-1 putatively con-
tains four myristylation sites, three binding sites for SH3 do-
main  containing  proteins,  two  potential  EF-hand  domains, 
and  a  coiled-coil  domain  at  the  C-terminus,  and  therefore, 
may have a role as a small adaptor protein involved in cal-
cium signaling (1). In accordance with this prediction, swi-
prosin-1  was  implicated  in  phosphotyrosine-based  signaling 
events involved in the cellular stimulation of early growth fac-
tor  (EGF)
3  and  in  actin  rearrangement  (13).  By  utilizing 
HMC-1 cell line, which was established from a patient with 
mast cell leukemia, we studied whether swiprosin-1 involves 
in the expression of human cytokines and chemokines. The 
results presented here strongly demonstrate that swiprosin-1 
potentially acts as a regulator for cytokine expression and ac-
tivation  of  mast  cells.
MATERIALS AND METHODS
Antibodies and reagents
Goat polyclonal antibody to swiprosin-1 was from Imgenex 
(San Diego, CA). Antibodies to p-PI3K, p-Akt, and GFP were 
from Cell Signaling Technology, Inc (Beverly, MA). HRP-con-
jugated anti-goat, anti-rabbit, and anti-mouse IgGs were from 
GE  Healthcare  (Chalfont  St.  Giles,  United  Kingdom).  SB-
203580, PD98059, MG132, cyclosporine A, and PP2 were pur-
c h a s e d  f r o m  C a l b i o c h e m - B e h r i n g  ( L a  J o l l a ,  C A ) .  T o t a l  R N A 
isolation  reagent  was  from  WelPrep
TM  Join  Bio  Innovation 
(Daegu, South Korea). Maxime RT Premix (oligo dT primer), 
Maxime PCR PreMix, and a plasmid purification kit were from 
iNtRON Biotechnology (Daejon, South Korea). SYBR premix 
Ex Taq was from Takara Bio Inc (Shiga, Japan). The dual-lu-
ciferase reporter assay system was from Promega Corporation 
(Madison,  WI).  The  ELISA  kit  for  hIL-8  was  from  R&D 
Systems  (Minneapolis,  MN).  All  other  reagents  used  in  this 
study  were  purchased  from  Sigma  Chemical  Co  (St.  Louis, 
MO).
Cell culture
HMC-1 cells were cultured in IMDM medium. Jurkat T and 
M o l t - 4  T  c e l l s  ( T  c e l l s ) ,  R a j i  B  c e l l s  ( B  c e l l s ) ,  T H P - 1  c e l l s  
(monocytes),  and  293-T  and  CHO-K1  cells  (epithelial  cells) 
were maintained in RPMI 1640 medium. J774A.1 cells (ma-
crophages), HT-29 cells (epithelial cells), COS-7 cells (fibro-
b l a s t s ) ,  a n d  R B L - 2 H 3  c e l l s  ( m a s t  c e l l s )  w e r e  c u l t u r e d  i n  
DMEM medium. HUVECs were cultured in EBM medium. All 
culture media used in this study were supplemented with 10% 
heat inactivated FBS, 100 units/ml penicillin G, and 100μg/ 
ml  streptomycin.
Recombinant DNA constructs
To generate the swiprosin-1/pEGFP-C1 construct, the human 
swiprosin-1  clone  coding  for  the  full-length  open  reading 
frame  of  swiprosin-1  in  the  pOTB7  vector  was  purchased 
from RZPD German Resource Center (Berlin, Germany). This 
was used as a template, and a PCR amplification was per-
formed using the primers: sense 5’-AAGAATTCTATGGCCAC-
GGACGAGCTGGCCACC-3’  containing  the  EcoRI  restriction 
site and anti-sense 5’-TTTGGATCCCTACTTAAAGGTGGACT-
GCAGCTC-3’ containing the Bam HI restriction site. The PCR 
product was subcloned as a EcoRI/Bam HI fragment into a 
pEGFP-C1 vector (Clontech Laboratory, Inc.) of a neomycin 
resistant gene, resulting in an in-frame fusion of swiprosin-1 
t o  t h e  C O O H  t e r m i n u s  o f  G F P .  T h e  a m i n o  a c i d  s e q u e n c e s 
of a linker polypeptide between EGFP and swiprosin-1 were 
SGLRSRAQAS (10 aa). To generate wild-type swiprosin-1 in 
a pcDNA3 vector or in a pHJ-1 vector (lentiviral vector), swi-
prosin-1 cDNA from the pOTB7 vector was transferred into 
the pcDNA3 vector by EcoRI/XhoI or the pHJ-1 vector by Not 
I restriction digestions and confirmed by automated sequenc-
ing.Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Establishment of stable cell lines
Stable  HMC-1  transfectants  were  established  using  the  Nu-
cleofector  device  and  corresponding  kits  (Amaxa,  Cologne, 
Germany)  by  introducing  pEGFP-C1  or  swiprosin-1/pEGFP- 
C 1  c D N A  f o l l o w e d  b y  s e l e c t i o n  w i t h  1  m g / m l  g e n e t i c i n  
(Invitrogen).  The  cells  were  then  subjected  to  a  FACS  and 
sorted  to  selectively  obtain  GFP-positive  cells.  They  were 
then  cultured  in  complete  medium  supplemented  with  the 
same concentrations of antibiotics. The stable cells that ex-
p r e s s e d  E G F P  o r  E G F P  f u s e d  w i t h  s w i p r o s i n - 1  w e r e  d e s -
ignated as H-GFP cells and H-swip-1_GFP cells, respectively. 
RNA isolation and RT-PCR
Cells from the tissue samples or in vitro cultures were har-
vested and total RNA was isolated using the WelPrep
TM JBI 
method (iNtRON Biotechnology, Daejon, Korea) according to 
the manufacturer’s instructions. Reverse transcription of the 
RNA was performed using oligo dT primer Maxime RT-PCR 
PreMix (iNtRON Biotechnology, Daejon, Korea). Two micro-
grams of RNA was transferred to an oligo dT primer mixture 
tube. The reaction volume was 20μl. cDNA synthesis was 
performed  at 45
oC  for  60  min,  followed  by  RT  inactivation 
at 95
oC for 5 min. Thereafter, the RT-generated DNA was di-
luted  to  40μl  volume  with  distilled  water.  The  diluted 
RT-generated DNA (2μl) was amplified using Maxime PCR 
PreMix (iNtRON Biotechnology, Daejon, Korea). The primers 
used  for  cDNA  amplification  were  as  follows:  hSwip-1(p1), 
sense 5’-ATCTTCCGCAAGGCGGCGGCCGGGGAG-3’ and an-
tisense 5’-GACTGCAGCTCCTTGAAGGCCGCTTTC-3’; hSwip-1 
(p2),  sense  5’-CTCGAGGCCACAGTTATGCAA-3’  and  anti-
sense 5-’TAAGGCAAACGCA-3’; rSwip-1(p1), Sense 5’-CGTT-
ATGCAATGTTCCTCGTGTCACTG-3’ and antisense 5’-GATT-
CTCACAGGTTCTAAGACCGAAAA-3’;  rSwip-1(p2),  Sense  5’- 
TACAATGCCTCAAGAGCCCCCGGGACC-3’ and antisense 5’- 
CCAAAAGTAAAGGGAATTTATATTCCT-3’;  mSwip-1,  sense 
5’-GAGGCTCCCGACGAGACTGCCCAGGCG-3’ a nd  an ti se ns e 
5’-CCGGAAGCTGAGTTTGCTGTCGAAATC-3’;  hIL-3,  sense 
5’-CTTTGCCTTTGCTGGACTTC-3’ and antisense 5’-CGAGG-
CTCAAAGTCGTCTG-3’;  h I L - 8 ,  s e n s e  5 ’-GTGCAGTTTTGCC-
AAGGAGT-3’ and antisense 5’-CTCTGCACCCAGTTTTCCTT-3’; 
hTNF-α, sense 5’-GGCTCCAGGCGGTGCTTGTTC-3’ and an-
tisense 5’-AGACGGCGATGCGGCTGATG-3’; hGAPDH, sense 
5’-CGGAGTCAACGGATTTGGTCGTAT-3’  and  antisense  5’- 
AGCCTTCTCCATGGTGGTGAAGAC-3’;  rβ-actin,  sense  5’- 
ATTGAACACGGCATTGTCAC-3’ and antisense 5’-GTCTCAAA-
CATGATCTGGGTC-3’. Amplification conditions were denatu-
ration at 94
oC for 30 s, annealing at 58∼68
oC for 20 s, and 
extension at 72
oC for 40 s for 30∼35 cycles. The PCR prod-
ucts  were  resolved  and  visualized  on  a  1  or  1.5%  agarose 
gel  and  stained  with  ethidium  bromide. 
Real-time quantitative RT-PCR
In all the experiments, the expression levels of the examined 
genes were evaluated by real-time RT-PCR, unless otherwise 
indicated. PCR amplification was performed in DNA Engine 
Opticon for a continuous fluorescence detection system (MJ 
Research, Waltham, MA) in a total volume of 20μl containing 
2μl  of  cDNA/control  and  gene  specific  primers  using  the 
SYBR premix Ex Taq kit (Takara, Shiga, Japan). The PCR was 
performed under the following conditions: 94
oC for 30 s, 58
∼68
oC for 30 s, 72
oC for 30 s, plate read (detection of fluo-
rescent product) for 40 cycles, followed by 7 min of extension 
at 72
oC. A melting curve analysis was done to characterize 
the  dsDNA  product  by  slowly  raising  the  temperature 
(0.2
oC/s) from 65
oC to 95
oC with fluorescence data collected 
at 0.2
oC intervals. The levels of expression (of swiprosin-1, 
IL-3, IL-8, and TNF-α) that were normalized by GAPDH or 
β-actin were expressed as a relative value (i.e., percentage) 
of the maximum. The result of the maximum level in each 
e x p e r i m e n t  w a s  c o n s i d e r e d  a s  1 0 0 % .
Immunofluorescence staining and confocal imaging 
analysis
Stable  HMC-1  cells  (H-GFP  or  H-swip-1_GFP;  1×10
5)  or 
COS-7 cells (transfected with GFP or swip-1_GFP) were seed-
ed  onto  the  poly-L-lysine  (PLL)-coated  or  uncoated  18-mm 
glass coverslips. The cells were then fixed with 3.7% form-
aldehyde for 10 min and washed twice with 1X PBS. F-actin 
was detected by staining with phalloidin-TRITC (50μg/ml). 
293-T  cells  (swiprosin-1  transfectants)  were  also  grown  on 
glass  coverslips.  The  cells  were  fixed  as  described  above, 
then incubated with primary goat polyclonal swiprosin-1 anti-
body,  followed  by  secondary  FITC-conjugated  anti-goat  an-
tibody. The localization of swiprosin-1 and actin was exam-
i n e d  w i t h  a n  F V 1 0 0 0  c o n f o c a l  l a s e r  s c a n n i n g  m i c r o s c o p e  
(Olympus Corporation, Japan) equipped with 40×, 63×, and 
100× objectives. In some cases, cells were not fixed and live 
images were obtained by confocal microscopy. For the co-lo-
calization analysis, the Z section cutting area through the ap-
ical surface was chosen. The overlapping degree of intensity 
(ODI)  was  calculated  by  FLUOVIEW  software  version  1.5. Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Figure 1. Expression analysis of swiprosin-1 mRNA by RT-PCR. (A) Expression of swiprosin-1 mRNA in various cell types. RNAs were prepared 
from cell lines including Jurkat T and Molt-4 T (T cells), Raji B (B cells), THP-1 (monocytes), 293T, CHO-K1, HT-29 (epithelial cells), and rat
RBL-2H3 (mast cells), and then the mRNA levels of swiprosin-1 were determined by RT-PCR. Note: Expression of swiprosin-1 in RBL-2H3 was 
determined by using rat swiprosin-1-specific primers. (B) Induction of swiprosin-1 in HMC-1 cells by PMA/A23187. HMC-1 cells were treated 
with PMA (200 nM) and A23187 (1μM). At the indicated time points, the expression of swiprosin-1 was determined by RT-PCR. (C) Induction 
of swiprosin-1 in RBL-2H3 cells by cross-linking of FcεRI. RBL-2H3 cells were sensitized with anti-DNP-IgE (1μg/ml) for 18 h, and then the
cells were challenged with DNP-HSA (1μg/ml). At the indicated time points, the expression of swiprosin-1 was determined by RT-PCR. The
information of primers (P1 and P2) was described in the Materials and Methods. Amplification of GAPDH and hTNF-α were used as an internal
control and an activated mast cell marker, respectively. All data are from at least three separate experiments.
The  co-localization  percentage  was  then  derived  from  the 
ODI,  multiplying  by  100.
    For  live-cell  time-lapse  confocal  imaging,  H-swip-1_GFP 
cells were seeded at 2×10
5 on 18-mm glass coverslips mount-
ed in a chamber device. Cells were allowed to settle for 10 
min  at  37
oC  and  then  activated  by  adding  PMA/A23187. 
During the live-cell imaging, the chamber devices were main-
tained at 37
oC in a 5% CO 2 atmosphere, using a live-cell in-
strument system (Chanlide
Ⓡ Inc., Korea).  A  confocal  series 
of  fluorescence  and  differential  interference  contrast  (DIC) 
images were simultaneously obtained at 20-s intervals using 
an 100× oil immersion objective on FV1000 confocal micro-
scope (Olympus). The images were processed and assembled 
into movies using Olympus FLUOVIEW software version 1.5.
Cell extract preparation and Western blot analysis
For  the  analysis  of  swiprosin-1,  GFP,  p-PI3K,  and  p-Akt 
HMC-1  cells  (parent  or  transfected  cells)  were  rinsed  twice 
with ice-cold PBS and then lysed in ice-cold lysis buffer (10 
m M  T r i s - H C l ,  p H  7 . 4 ,  c o n t a i n i n g  5 0  m M  N a C l ,  1 %  T r i t o n  
X-100, and a protease inhibitor cocktail tablet). Cell lysates 
were centrifuged at 14,000 rpm for 20 min at 4
oC and equal 
amounts of protein supernatant were mixed with a one-fourth 
volume of 4X SDS sample buffer, boiled for 5 min, and then 
separated through an 8 or 10% sodium dodecyl sulfate-poly-
acrylamide  gel.  After  electrophoresis,  proteins  were  trans-
f e r r e d  t o  a  n i t r o c e l l u l o s e  m e m b r a n e  b y  m e a n s  o f  t h e  
Trans-Blot SD semidry transfer cell (Bio-Rad, Hercules, CA). 
The membrane was blocked in 5% skim milk (1 h), rinsed, 
and  incubated  overnight  at  4
oC  w i t h  p r i m a r y  a n t i b o d i e s  i n  
TBS containing 0.1% Tween 20 (TBS-T) and 3% skim milk. 
Excess primary Ab was then removed by washing the mem-
brane three times in TBS-T, and the membrane was incubated 
with 0.1μg/ml horseradish peroxidase-labeled secondary Ab 
( a g a i n s t  g o a t ,  r a b b i t ,  o r  m o u s e )  f o r  2  h .  F o l l o w i n g  t h r e e  
washes in TBS-T, bands were visualized by ECL western blot-
ting  detection  reagents  and  exposed  to  x-ray  film.
IL-8 measurement and histamine release assay
S ta bl e H M C- 1 c e lls  ( H- G F P o r H -s wi p- 1_ G F P;  2× 1 0
6) were 
seeded into 12-well plates. The cells were further stimulated 
with  PMA  (200  nM)/A23187  (1μM).  At  the  indicated  time 
points,  supernatants  were  collected  and  IL-8  and  histamine 
levels were measured by ELISA (R&D Systems), according to 
the  manufacturer’s  instructions.
Statistical analysis
The  mean  values  were  calculated  from  data  taken  from  at 
least three (usually four or more) separate experiments con-
ducted on separate days. Where significance testing was per-
formed,  an  independent  t  test  (Student’s;  two  populations) 
was  used.  A  p  value  of  less  than  0.05  was  considered  an 
indicator  of  statistical  significance.Swiprosin-1 Regulates HMC-1 Cytokine Expression
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RESULTS
Swiprosin-1 is expressed in mast cells and up-re-
gulated during mast cell activation
We  examined  the  expression  of  swiprosin-1  in  various  cell 
types and found that it is expressed in most immune cells, 
including T and B cells, monocytes, and mast cells. It is also 
expressed in some non-immune cells, such as epithelial and 
endothelial cells, though there are some degrees of difference 
in terms of expression level (Fig. 1A). These results suggest 
that swiprosin-1 is not restricted to T and B cells but preva-
lently expressed in most cell types, including mast cells. With 
the semi-quantitative RT-PCR and real-time quantitative PCR, 
we confirmed that swiprosin-1 is significantly over-induced in 
HMC-1 cells when stimulated with PMA (100 nM)/A23187 (1
μM) (Fig. 1B). Swiprosin-1 was also over-induced in the rat 
mast cell line RBL-2H3 through the FcεRI cross-linking, by 
treatment with IgE and DNP-HSA, while the induction kinetics 
was faster than that of HMC-1 cells (2 to 6 h after stimulation) 
(Fig.  1C).
Swiprosin-1 enhances mast cell activation by phor-
bol ester and calcium ionophore
Induction of swiprosin-1 during mast cell activation, coupled 
with the fact that swiprosin-1 has a potential for a novel sig-
n a l i n g  a d a p t o r  p r o t e i n  ( 1 , 2 , 4 , 1 3 ) ,  s u g g e s t s  t h a t  s w i p r o s i n - 1  
may be involved in mast cell activation as a signal adaptor 
molecule. To verify this, we generated HMC-1 cells that tran-
siently or stably over-express either GFP (H-GFP cells) alone 
or GFP fused to swiprosin-1 (H-swip-1_GFP cells) (data not 
shown). As shown in Fig. 2A∼C, over-expression of swipro-
sin-1  significantly  enhanced  PMA/A23187-induced  cytokine 
expression. This result was consistent with the previous re-
sults  (3).  In  addition,  it  enhanced  histamine  release  by 
PMA/A23187  stimulation  (Fig.  2D).
    We next tested whether silencing swiprosin-1 can alter the 
cytokine expression in HMC-1 cells. To this end, we trans-
fected HMC-1 cells with siRNA targeting swiprosin-1, and then 
evaluated the cells for cytokine expression. However, knock-
down  of  swiprosin-1  only  showed  a  modest  effect  on 
PMA/A23187-induced  IL-3  and  IL-8  mRNA  expression  in 
HMC-1  cells  (data  not  shown),  suggesting  that  swiprosin-1 
has  gain-of-function  characteristics.
Cytochalasin B, an actin depolymerizing agent, and 
wortmannin, a PI3K inhibitor, selectively inhibit cyto-
kine expression in swiprosin-1 expressing HMC-1 cells
The  modest  effect  of  swiprosin-1  knock-down  on  cytokine 
expression by PMA/A23187 may suggest that swiprosin-1 is 
not involved in the main pathway of cytokine expression but 
has an additive effect if over-expressed, presumably by mod-
ulating  another  pathway.  We  therefore  employed  various 
pharmacologic agents to systemically control the intracellular 
signaling  pathways  potentially  involved  in  mast  cell  acti-
vation.
    First,  both  NF-κB  a n d  N F - A T  p a t h w a y s  a r e  c r i t i c a l  f o r  
IgE-mediated cytokine production (14,15). We examined the 
effects of two pharmacologic agents, MG132 and cyclosporine 
A,  on  PMA/A23187-induced  cytokine  expression  in  both 
H-GFP  cells  and  H-swip-1_GFP  cells.  As  shown  in  Fig.  3A 
(left), both of these agents significantly suppressed cytokine 
expression in both cells to almost the same degree. Second, 
MAPK signaling pathways are also involved in cytokine ex-
pression in mast cells (16-18). Thus, the effects of two phar-
macologic inhibitors of ERK and p38 kinase, PD98059 (10μ
M) and SB203580 (10μM), respectively, were examined. As 
shown in Fig. 3A (right), both of the inhibitors significantly 
inhibited  PMA/A23187-induced  cytokine  expression  in  both 
cells. Taken together, the above results suggest that swipro-
sin-1 lies at least upstream or at the site of two main signaling 
pathways  in  terms  of  cytokine  expression  in  HMC-1  cells.
  Third, both Src family kinases and PI3K are central players 
in  mast  cell  degranulation  mediated  by  the  cross-linking  of 
FcεR1  (7),  but  are  not  well  understood  in  cytokine  ex-
pression of HMC-1 cells mediated by phorbol ester and cal-
cium ionophores. We therefore tested whether enhanced cy-
tokine  expression  in  H-swip-1_GFP  is  also  related  to  these 
kinases.  As  shown  in  Fig.  3B  (left) ,  P P 2 ,  a  S r c  k i n a s e  i n -
hibitor,  significantly  inhibited  cytokine  expression  in  both 
H-GFP and H-swip-1_GFP cells, suggesting a requirement of 
Src  family  kinases  in  PMA/A23187-induced  cytokine  ex-
pression in HMC-1 cells. Interestingly, however, wortmannin, 
a  PI3K  inhibitor,  only  inhibited  cytokine  expression  in  H- 
swip-1_GFP cells (Fig. 3B, left). This result suggests that swi-
prosin-1  may  influence  cytokine  expression  in  HMC-1  cells 
thorough  activation  of  the  PI3K  pathway  while  the  PI3K  is 
not  mainly  involved  in  PMA/A23187-induced  cytokine  ex-
pression. Notably, we found that treatment with HMC-1 cells 
with  PMA/A23187  resulted  in  no  significant  effect  on  the Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Figure 2. Ectopic expression of swiprosin-1 enhances mast cell activation by phorbol ester and calcium ionophore. (A∼D) Over-expression of
swiprosin-1 enhanced PMA/A23187-induced cytokine expression and histamine release. H-GFP or H-swip-1_GFP cells were treated with PMA 
(200 nM) for various times, and then the expression of cytokines were determined by RT-PCR (A) and quantitative RT-PCR (B). The supernatant
was also used to determine IL-8 secretion (C) and histamine release (D). Amplification of GAPDH was used as an internal control. Data represent
three separate experiments. The data shown in the bar graphs represent mean±SD values of triplicate experiments.
phosphorylation of PI3K, while p-Akt, a down-stream effector 
o f  P I 3 K ,  w a s  s l i g h t l y  i n c r e a s e d  5 ∼3 0  m i n  a f t e r  t r e a t m e n t  
(Fig. 4). In contrast, both p-PI3K and p-Akt were observed 
in  H-swip-1_GFP  cells  even  before  treatment  (0  min)  (Fig. Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Figure 3. Inhibition of cytokine expression by various pharmacologic agents in HMC-1 cells expressing GFP or swip-1_GFP. (A, B) H-GFP or
H-swip-1_GFP cells were pretreated for 30 min with or without various pharmacologic inhibitors including MG132 (1μM), cyclosporine A (CSA, 
1μg/ml), PD98059 (PD, 10μM), SB203580 (SB, 10μM), wortmannin (WOT, 100 nM), PP2 (10μM), colchicines (Col, 20μM), and cytochalasin 
B (CTB, 1μg/ml). Then the cells were further stimulated for 4 h with or without PMA (200 nM)/A23187 (1μM). The expression of cytokines
was determined by RT-PCR (top) and quantitative RT-PCR (bottom). Amplification of GAPDH was used as an internal control. Data represent 
three separate experiments. The data shown in the bar graphs represent mean±SD values of triplicate experiments.
4).
    Fourth, PI3K also has an important regulatory function for 
receptor-mediated  cytoskeletal  rearrangements  in  mast  cells 
(19,20). We therefore evaluated the potential involvement of 
two of the most important components of the cytoskeleton, 
actin  and microtubule. It has been reported that disruption 
of actin microfilaments by cytochalasin B enhanced the de-
granulation  response  in  RBL-2H  mast  cells  (21,22).  In  con-
trast,  microtubule  disruption  is  known  to  suppress  the  de-
granulation response through inhibition of calcium influx in 
the same cells (23). As shown in Fig. 3B (right), microtubule 
depolymerizer  colchicine  significantly  suppressed  cytokine 
expression in both H-GFP and H-swip-1_GFP cells, suggest-
ing that microtubules are also important in PMA/A23187-in-
duced  cytokine  expression  in  HMC-1  cells.  However,  actin 
depolymerizer  cytochalasin  B  inhibited  cytokine  expression 
t h a t  w a s  p r o d u c e d  o n l y  i n  H - s w i p - 1 _ G F P  c e l l s  ( F i g .  3 B ,  
right). These results demonstrate that actin polymerization is 
not normally involved in cytokine expression of HMC-1 cells 
stimulated  by  PMA/A23187.  However,  the  present  results 
strongly imply that swiprosin-1 may act through regulation of 
PI3K  and  actin  regulation.
Swiprosin-1 localized in actin-rich microvilli-like re-
gion in mast cells
In  many  cases,  localization  of  proteins  in  specialized  sites 
within  cells  reflects  their  specific  functions.  Moreover,  re-
duced cytokine expression in H-swip-1_GFP cells by actin de-
polymerizer cytochalasin B suggests a specific role of swipro-
sin-1  in  association  with  the  actin  cytoskeleton  (Fig.  3B, 
right). We therefore examined localization of swiprosin-1 in 
HMC-1 cells and other cell types using confocal microscopy. 
As shown in Fig. 5A, swip-1_GFP was highly localized in mi-
crovilli-like protrusions of HMC-1 cells, while GFP was dis-
tributed through the entire cytosol and nucleus. To better un-
derstand  this  contrast,  wild-type  swiprosin-1  (without  GFP) 
was also transfected in 293T cells and stained with antibody 
against  swiprosin-1  followed  by  FITC-conjugated  secondary Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Figure 3. Continued.
Figure 4. Ectopic expression of swiprosin-1 increases phosphorylation
of PI3K and Akt in HMC-1 cells. H-GFP or H-swip-1_GFP cells were 
treated with PMA (200 nM)/A23187 (1μM). At the indicated time 
points, the cells were lysed and p-PI3K and p-Akt were determined 
by western blot.
antibody.  We  then  evaluated  the  localization  by  high  reso-
lution confocal microscopy. Interestingly, swiprosin-1 was no-
tably accumulated in the membrane apical ridge area of 293T 
cells (Fig. 5B). This observation may agree with the report 
t h a t  s w i p r o s i n - 1  i s  a  l i p i d  r a f t  p r o t e i n  i n  B  c e l l s  ( 4 ) .  S i n c e 
F-actin is known to be enriched in the microvilli-like region 
(24), we tested whether swiprosin-1 is localized with F-actin 
i n b ot h  H M C- 1  a nd  CO S- 7 c el ls.  As  s ho w n in  F ig .  5 C an d 
D, swiprosin-1 was highly co-localized with F-actin in both 
HMC-1  and  COS-7  cells,  and  re-localized  along  with  the 
m o v e m e n t  o f  F - a c t i n  i n  C O S - 7  c e l l s ,  w h e n  t h e  c e l l s  w e r e  
stimulated  with  PMA  (Fig.  5D).  Collectively,  localization  of 
swiprosin-1  in  the  microvilli-like  region  (Fig.  5A)  or  mem-
brane ridge region (Fig. 5B) and its association with F-actin 
(Fig. 5C, D), together with the fact that the actin-disrupting 
agent cytochalasin B inhibits cytokine expression only in H- 
swip-1_GFP cells, suggest that swiprosin-1 functions through 
actin  regulation  and  reorganization.
DISCUSSION
Molecules produced by mast cells also can activate mast cells 
in an autocrine manner. For example, TNF-α is one of the 
major cytokines that autocrinely activates HMC-1 cells (25). 
In a similar manner, ectopic expression of swiprosin-1 aug-
mented  PMA/A23187-induced  NF-κB  promoter  activity  as 
w e l l  a s  c y t o k i n e  e x p r e s s i o n  ( 3 ) .  I n  t h e  p r e s e n t  r e p o r t ,  w e  
demonstrate that localization of swiprosin-1 in microvilli-like 
membrane protrusion with F-actin may be important in acti-Swiprosin-1 Regulates HMC-1 Cytokine Expression
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Figure 5. Swiprosin-1 is localized in
actin-rich microvilli-like membrane 
protrusions in mast cells. (A) H-GFP
or H-swip-1_GFP cells were ad-
hered on glass coverslips, and then
were imaged using confocal micro-
scopy with serial z-sections. Images 
were represented as single series 
images and reconstituted images of 
the z-axis. (B) 293T cells were tra-
nsfected with swiprosin-1/pcDNA3, 
then the cells were stained anti- 
swiprosin-1 antibody, followed by 
incubation with the FITC-conjugated
secondary antibody. The cells were 
then imaged by confocal micro-
scopy. (C, D) HMC-1 cells express-
ing GFP or swip-1_GFP (C) or 
COS-7 cells expressing swip-1_GFP 
(D) were fixed and stained with 
phalloidin-TRITC. The cells were 
then imaged by confocal micro-
scopy. Co-localization analysis was 
carried out as described in Materials
and Methods. Scale bars, 10μm.
vating  mast  cells  because  either  disruption  of  actin  by  cy-
t o c h a l a s i n  B  o r  i n h i b i t i o n  o f  P I 3 K  b l o c k e d  c y t o k i n e  e x -
pression  only  in  swiprosin-1-overexpressing  cells.
    In  the  previous  study,  we  unambiguously  demonstrated 
that swiprosin-1 expression is transcriptionally regulated both 
in vitro in a model of phorbol ester-induced activation and Swiprosin-1 Regulates HMC-1 Cytokine Expression
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in vivo in pathological models. The results strongly suggested 
that swiprosin-1 may be importantly involved in physiological 
and/or  pathological  processes.  Furthermore,  increased  ex-
pression of swiprosin-1 in tissue models of PCA and atopic 
dermatitis  suggested  a  potential  role  for  swiprosin-1  in  in-
flammatory responses (3). With this respect, the current re-
sults strongly demonstrate that swiprosin-1 is involved in the 
inflammatory  responses  by  exp r e s s i n g  a n d  r e l e a s i n g  c y -
tokines.
    Localization of proteins in specialized sites in the cells can 
reflect their specific functions (26-28). For example, SLP-76, 
an adaptor protein that is critical for FcεRI-induced calcium 
flux,  degranulation,  and  cytokine  secretion  in  mast  cells,  is 
found  in  the  cytosol  of  unstimulated  cells.  Upon  FcεRI 
cross-linking, SLP-76 translocates to the cell membrane, form-
ing clusters that co-localize with the FcεRI, the tyrosine kin-
ase Syk, the adaptor LAT, and phosphotyrosine. Disruption 
of this localization has been reported to inhibit FcεRI-medi-
ated signaling in mast cells (27). In accordance with this, the 
present finding that the highest concentration of swiprosin-1 
in the microvilli-like membrane structure implies that this pro-
tein may function by forming signaling complexes in the plas-
ma membrane or by associating with actin or actin regulatory 
molecules. Moreover, reduction of actin contents by over-ex-
pression of swiprosin-1 further supports its potential role in 
actin reorganization. Indeed, the proline-rich element in the 
predicted secondary structure of swiprosin-1 is known as a 
potential binding site for the SH3 domain (2), the best-charac-
terized member of the growing family of protein-interaction 
modules involved in signaling to the dynamic actin networks 
(29,30). In accordance with the predicted secondary structure, 
our  unpublished  results  revealed  that  deletion  of  the  pro-
line-rich element in swiprosin-1 significantly reduced its asso-
ciation  with  F-actin  in  COS-7  cells  (data  not  shown).
    Based on the evidence regarding the physical or functional 
association of swiprosin-1 with actin in the current study, it 
is not surprising that disruption of actin polymerization by cy-
tochalasin B effectively inhibits cytokine expression in HMC-1 
cells. Induction of p-PI3K and p-Akt and inhibition of cyto-
kine expression by wortmannin also implies that swiprosin-1 
affects the PI3K pathway coupled with the regulation of actin 
dynamics. However, the fact that targeted knockdown of swi-
prosin-1 showed a modest effect on cytokine expression may 
suggest that swiprosin-1 is not involved in the main pathways 
of cytokine expression but has an additive effect if over-in-
duced,  presumably  activating  actin  reorganization  in  mast 
cells. We are now undertaking a study to identify the poten-
tial phosphorylation sites of swiprosin-1 and their implications 
in swiprosin-1-mediated activation of mast cells. In addition, 
we are planning to identify potential binding partners of swi-
prosin-1 to understand the mechanisms whether or how swi-
prosin-1 interacts with actin and regulates mast cell activation. 
One intriguing result in this study is that swiprosin-1 is rapidly 
(＜5 min) and dramatically redistributed to the secreting gran-
ules of HMC-1 cells during activation by PMA/A23187 (data 
not shown). The result implies that swiprosin-1 may also be 
involved  in  the  process  of  mast  cell  degranulation  by  cou-
pling  with  actin  dynamics.
    The  mast  cell  is  a  central  player  in  allergy  and  asthma. 
Activation of these cells induces the release of preformed in-
flammatory  mediators  localized  in  specialized  granules  and 
the  de  novo  synthesis  and  secretion  of  cytokines,  chemo-
kines,  and  eicosanoids  (7).  Upon  stimulation,  mast  cell  re-
sponse can be regulated by the balance of both positive and 
negative intracellular molecular events (7). Here, we suggest 
that swiprosin-1 is a novel regulator for the positive feedback 
activation of mast cells. Once induced, this protein is highly 
localized  in  the  actin-rich  microvilli-like  membrane  pro-
trusions in mast cells. In pathological situations, this protein 
may regulate local allergic or inflammatory responses by am-
plifying  signals  that  are  required  for  mast  cell  activation.
ACKNOWLEDGEMENTS
This work was supported by the Korea Research Foundation 
Grant  (R05-2004-000-11388-0).
CONFLICTS OF INTEREST
The  authors  have  no  financial  conflict  of  interest.
REFERENCES
1. Vuadens  F,  Rufer  N,  Kress  A,  Corthésy  P,  Schneider  P, 
Tissot  JD:  Identification  of  swiprosin  1  in  human  lym-
phocytes.  Proteomics  4;2216-2220,  2004
2. Avramidou  A,  Kroczek  C,  Lang  C,  Schuh  W,  Jäck  HM, 
Mielenz D: The novel adaptor protein Swiprosin-1 enhan-
ces BCR signals and contributes to BCR-induced apoptosis. 
Cell  Death  Differ  14;1936-1947,  2007
3. Thylur RP, K im  Y D , Kw on M S, O h H M , Kw on H K , Kim 
SH, Im SH, Chun JS, Park ZY, Jun CD: Swiprosin-1 is ex-
pressed in mast cells and up-regulated through the protein 
kinase C beta I/eta pathway. J Cell Biochem 108;705-715, Swiprosin-1 Regulates HMC-1 Cytokine Expression
T.P. Ramesh, et al.
284 IMMUNE NETWORK http://www.ksimm.or.kr Volume 9 Number 6 December 2009
2009
4. Mielenz D, Vettermann C, Hampel M, Lang C, Avramidou 
A, Karas M, Jäck HM: Lipid rafts associate with intracellular 
B cell receptors and exhibit a B cell stage-specific protein 
composition.  J  Immunol  174;3508-3517,  2005
5. Kemp SF, Lockey RF: Anaphylaxis: a review of causes and 
mechanisms.  J  Allergy  Clin  Immunol  110;341-348,  2002
6. Metzger  H,  Alcaraz  G,  Hohman  R,  Kinet  JP,  Pribluda  V, 
Q u a r t o  R :  T h e  r e c e p t o r  w i t h  h i g h  a f f i n i t y  f o r  i m m u -
noglobulin  E.  Annu  Rev  Immunol  4;419-470,  1986
7. Rivera  J,  Gilfillan  AM:  Molecular  regulation  of  mast  cell 
activation.  J  Allergy  Clin  Immunol  117;1214-1226,  2006
8. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 
77;1033-1079,  1997
9. Church MK, Levi-Schaffer F: The human mast cell. J Allergy 
Clin  Immunol  99;155-160,  1997
10. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, 
Paul WE: Mast cell lines produce lymphokines in response 
to cross-linkage of Fc epsilon RI or to calcium ionophores. 
Nature  339;64-67,  1989
11. Wodnar-Filipowicz A, Heusser CH, Moroni C: Production 
o f  t h e  h a e m o p o i e t i c  g r o w t h  f a c t o r s  G M - C S F  a n d  i n t e r -
leukin-3 by mast cells in response to IgE receptor-mediated 
activation.  Nature  339;150-152,  1989
1 2 . G o rd o n  JR , G a lli S J: M a s t c e lls a s  a  so u rc e  o f b o th  p re-
formed and immunologically inducible TNF-alpha/cachec-
tin.  Nature  346;274-276,  1990
13. Blagoev  B,  Ong  SE,  Kratchmarova  I,  Mann  M:  Temporal 
analysis of phosphotyrosine-dependent signaling networks 
by  quantitative  proteomics.  Nat  Biotechnol  22;1139-1145, 
2004
14. Marquardt  DL,  Walker  LL:  Dependence  of  mast  cell  IgE- 
mediated  cytokine  production  on  nuclear  factor-kappaB 
activity.  J  Allergy  Clin  Immunol  105;500-505,  2000
1 5 . K a y e  R E , F ru m a n  D A , B ie re r B E , A lb e rs  M W , Z y d o w sk y 
LD, Ho SI, Jin YJ, Castells MC, Schreiber SL, Walsh CT, et 
al.: Effects of cyclosporin A and FK506 on Fc epsilon re-
ceptor type I-initiated increases in cytokine mRNA in mouse 
bone  marrow-derived  progenitor  mast  cells:  resistance  to 
FK506 is associated with a deficiency in FK506-binding pro-
tein FKBP12. Proc Natl Acad Sci U S A 89;8542-8546, 1992
16. Feoktistov  I,  Goldstein  AE,  Biaggioni  I:  Role  of  p38  mi-
togen-activated protein kinase and extracellular signal-regu-
lated  protein  kinase  kinase  in  adenosine  A2B  recep-
tor-mediated interleukin-8 production in human mast cells. 
Mol  Pharmacol  55;726-734,  1999
17. Park HH, Lee S, Oh JM, Lee MS, Yoon KH, Park BH, Kim 
JW, Song H, Kim SH: Anti-inflammatory activity of fisetin 
in  human  mast  cells  (HMC-1).  Pharmacol  Res  55;31-37, 
2007
18. Boudreau RT, Hoskin DW, Lin TJ: Phosphatase inhibition 
potentiates  IL-6  production  by  mast  cells  in  response  to 
FcepsilonRI-mediated activation: involvement of p38 MAPK. 
J  Leukoc  Biol  76;1075-1081,  2004
19. Samayawardhena LA, Kapur R, Craig AW: Involvement of 
Fyn kinase in Kit and integrin-mediated Rac activation, cy-
toskeletal  reorganization,  and  chemotaxis  of  mast  cells. 
Blood  109;3679-3686,  2007
20. Vosseller K, Stella G, Yee NS, Besmer P: c-kit receptor sig-
naling  through  its  phosphatidylinositide-3'-kinase-binding 
site and protein kinase C: role in mast cell enhancement 
of  degranulation,  adhesion,  and  membrane  ruffling.  Mol 
Biol  Cell  8;909-922,  1997
21. Frigeri L, Apgar JR: The role of actin microfilaments in the 
down-regulation of the degranulation response in RBL-2H3 
mast  cells.  J  Immunol  162;2243-2250,  1999
22. Oka T, Hori M, Tanaka A, Matsuda H, Karaki H, Ozaki H: 
IgE alone-induced actin assembly modifies calcium signal-
ing and degranulation in RBL-2H3 mast cells. Am J Physiol 
Cell  Physiol  286;C256-263,  2004
23. Oka T, Hori M, Ozaki H: Microtubule disruption suppresses 
allergic response through the inhibition of calcium influx 
in  the  mast  cell  degranulation  pathway.  J  Immunol  174; 
4584-4589,  2005
24. Edgar AJ, Bennett JP: Circular ruffle formation in rat baso-
philic leukemia cells in response to antigen stimulation. Eur 
J  Cell  Biol  73;132-140,  1997
25. Wong CK, Tsang CM, Ip WK, Lam CW: Molecular mecha-
nisms for the release of chemokines from human leukemic 
mast cell line (HMC)-1 cells activated by SCF and TNF-al-
p h a :  r o l e s  o f  E R K ,  p 3 8  M A P K ,  a n d  N F - k a p p a B .  A l l e r g y  
61;289-297,  2006
26. Rivera J, Arudchandran R, Gonzalez-Espinosa C, Manetz TS, 
Xirasagar S: A perspective: regulation of IgE receptor-medi-
ated mast cell responses by a LAT-organized plasma mem-
brane-localized signaling complex. Int Arch Allergy Immu-
nol  124;137-141,  2001
27. Silverman MA, Shoag J, Wu J, Koretzky GA: Disruption of 
SLP-76 interaction with Gads inhibits dynamic clustering of 
SLP-76  and  FcepsilonRI  signaling  in  mast  cells.  Mol  Cell 
Biol  26;1826-1838,  2006
28. Altman A, Villalba M: Protein kinase C-theta (PKCtheta): it's 
all  about  location,  location,  location.  Immunol  Rev  192; 
53-63,  2003
29. Mayer BJ: SH3 domains: complexity in moderation. J Cell 
Sci  114;1253-1263,  2001
30. Daly RJ: Cortactin signalling and dynamic actin networks. 
Biochem  J  382;13-25,  2004